Picosecond laser evaluated in melasma study
A study published by the American Society of Laser Medicine and Surgery reveals the efficacy of the 755-nm picosecond laser as a treatment for melasma in Asian women with darker skin types.
A recent study published by the American Society of Laser Medicine and Surgery evaluated the efficacy of a 755-nm picosecond laser with and without diffractive lens array (DLA) as a treatment for Asian patients with melasma.
Initially reported by
MORE:
Over the course of five months, patients were treated with the PicoSure 755-nm picosecond laser (Cynosure) and a fractionated beam on one side of the face and full beam on the other once per month.
Study results demonstrated significant improvement in pigment clearance on each treated side 6-months post-treatment. Meanwhile, researchers found physician-rating scores did not display statistically significant differences at any patient follow-ups. Results also found a lower incidence of post-inflammatory hyperpigmentation with the full-beam treatment.2
RELATED:
“A 755‐nm picosecond laser is safe and effective for the treatment of melasma in dark‐skinned individuals. The use of DLA does not provide additional benefit over the flat optics in clearing pigmentation,” writes the study authors.
More information on the study can be found at
References:
1. Hobbins, K. (2020, September 24). Study Examines Laser Treatment for Melasma. Retrieved September 24, 2020, from
2. Manuskiatti W, Yan C, Tantrapornpong P, Cembrano KAG, Techapichetvanich T, Wanitphakdeedecha R. A Prospective, Split-Face, Randomized Study Comparing a 755-nm Picosecond Laser With and Without Diffractive Lens Array in the Treatment of Melasma in Asians. Lasers Surg Med. 2020; epub ahead of print.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Articles
- Day 3 Recap: Maui Derm NP+PA Fall 2025
September 22nd 2025
- A Practical Update on Psoriasis and Vitiligo Treatment
September 22nd 2025
- Adapting to the Age of AI in Clinical Dermatology
September 22nd 2025
- Expert Insights on Uncommon Dermatoses from Walter Liszewski, MD
September 22nd 2025
- Nail Pathology in Clinical Practice with Phoebe Rich, MD
September 22nd 2025